Education
About Us
Working with TipRanks
Follow Us
Hoth Therapeutics Inc (HOTH)
NASDAQ:HOTH
Total Valuation
Hoth Therapeutics has a market cap or net worth of $10.40M. The enterprise value is .
Market Cap$10.40M
Enterprise Value
Share Statistics
Hoth Therapeutics has 13.17M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding13.17M
Owened by Insiders0.53%
Owened by Instutions0.11%
Financial Efficiency
Hoth Therapeutics’s return on equity (ROE) is -1.19 and return on invested capital (ROIC) is -118.89%.
Return on Equity (ROE)-119.04%
Return on Assets (ROA)-106.17%
Return on Invested Capital (ROIC)-118.89%
Return on Capital Employed (ROCE)-119.38%
Revenue Per Employee$29,769
Profits Per Employee-$3,753,789
Employee Count2
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Hoth Therapeutics is -0.58. Hoth Therapeutics’s PEG ratio is 0.01.
PE Ratio-0.58
PS Ratio0.00
PB Ratio0.69
Price to Fair Value0.69
Price to FCF-0.68
Price to Operating Cash Flow-0.68
PEG Ratio0.01
Income Statement
In the last 12 months, Hoth Therapeutics had revenue of $59.54K and earned -$7.51M in profits. Earnings per share was -$1.40.
Revenue$59.54K
Gross Profit$29.77K
Operating Income-$7.53M
Pretax Income-$7.51M
Net Income-$7.51M
EBITDA-5.48M
Earnings Per Share (EPS)-1.40
Cash Flow
In the last 12 months, operating cash flow was -$6.43M and capital expenditures $0.00, giving a free cash flow of -$8.02M billion.
Operating Cash Flow-$6.43M
Free Cash Flow-$8.02M
Free Cash Flow per Share-$0.61
Dividends & Yields
Hoth Therapeutics pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-146.32%
Earnings Yield-171.69%
Stock Price Statistics
Beta-0.16
52-Week Price Change-45.24%
50-Day Moving Average1.07
200-Day Moving Average0.95
Relative Strength Index (RSI)41.52
Average Volume (3m)1.04M
Important Dates
Hoth Therapeutics upcoming earnings date is Nov 10, 2020, TBA.
Last Earnings DateAug 13, 2020
Next Earnings DateNov 10, 2020
Ex-Dividend Date―
Financial Position
Hoth Therapeutics as a current ratio of 9.20, with Debt / Equity ratio of <0.01
Current Ratio9.20
Quick Ratio9.20
Debt to Market Cap<0.01
Net Debt to EBITDA0.85
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Hoth Therapeutics has paid -$2.05M in taxes.
Income Tax-$2.05M
Effective Tax Rate0.00%
Enterprise Valuation
Hoth Therapeutics EV to EBITDA ratio is 0.27, with an EV/FCF ratio of 0.32.
EV to Sales0.00
EV to EBITDA0.27
EV to Free Cash Flow0.32
EV to Operating Cash Flow0.32
Balance Sheet
Hoth Therapeutics has $8.02M in cash and marketable securities with $33.81K in debt, giving a net cash position of -$7.99M billion.
Cash & Marketable Securities$8.02M
Total Debt$33.81K
Net Cash-$7.99M
Net Cash Per Share-$0.61
Tangible Book Value Per Share$1.21
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Hoth Therapeutics is $4.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$4.00
Price Target Upside479.71%
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast
EPS Growth Forecast